10 April 2019 | News
This move broadens the geographic footprint of George Clinical in the Asia-Pacific region
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The new office and entity in Singapore, which was established in July, were requisites for George Clinical to act as a local clinical trial sponsor for the firm's international client base. James Cheong, appointed last month as COO, is now based out of the office.
Evon Hui, Head of Business Operations, East Asia said, "As a major trade center in the region, our presence in Singapore represents several new opportunities for our clients which they may not have thought we'd have access to previously. Similarly to what we provide in Hong Kong and Taiwan, we can now offer regulatory services include acting as local sponsor while managing IP importations, project management, safety and pharmacovigilance (PV) reporting services."
This move broadens the geographic footprint of George Clinical in the Asia-Pacific region and the firm can now provide project management, site management, local sponsorship and drug/medical device importation and exportation clinical trial services in Singapore.